Skin cancer includes basal cell skin cancer, squamous cell skin cancers and other rare types. These cancers tend to develop most often on skin that’s exposed to the sun and have a high cure rate.
The National Institute for Health and Care Excellence has recommended the use of the immunotherapy drug pembrolizumab (Keytruda) for some adults in England with a type of advanced melanoma skin cancer.
Over the last 10 years, melanoma skin cancer among men in the UK has increased by almost 50%.
Researchers have uncovered a new link between higher levels of testosterone in the blood and increased risk of melanoma skin cancer in men.
Ultraviolet radiation can cause a rare type of eye cancer, conjunctival melanoma.
New figures from Cancer Research UK and NIVEA SUN suggest that people are not protecting themselves properly from the sun in the UK.
Cancer Research UK scientists have developed a new way to analyse blood for evidence of cancer that could be up to ten times more sensitive than previous methods.
An immunotherapy and a targeted cancer drug were among the latest batch of NHS approvals from the Scottish Medicines Consortium (SMC).
Researchers have demonstrated an approach which, used in parallel with existing treatments, wipes out the ‘survival system’ of cancer cells.